♫musicjinni

Come to the DIA Annual Meeting in San Diego, June 21-25, 2009

video thumbnail
The DIA Annual Meeting is the biopharmaceutical industry's largest, longest running, best-value, global, multidisciplinary event. This year's program offers learning opportunities for EVERYONE and features the biggest names from industry, regulatory, and academia.

Today's changing economic and pharmaceutical climate demands your attendance at this year's Annual Meeting in San Diego.

No matter your area of expertise, job function, or interest, our program has been designed specifically with you in mind. Our program offers a variety of options.

Network with more than 8,700 colleagues
Showcase your products and services along with more than 550 exhibiting companies in attendance
Choose from more than 350 hot topic sessions and 34 tutorials across 26 content areas and 3 mega-tracks
Hear from over 1100 speakers, including representatives from FDA, EMEA, and other global regulatory agencies
Gain continuing education credits
Attend the Networking Reception aboard the USS Midway Museum
FREE Access to ALL Annual Meeting Content with full paid registration
IT'S A GLOBAL EVENT

The Annual Meeting welcomes attendees from all geographic locations, professional categories, and levels of responsibility making it the perfect venue for blending multidisciplinary learning with global networking opportunities.

Register today!
http://www.diahome.org

The Drug Discovery Process

About DIA

Developments in clinical trials regulation

505(b)(2) Planning: Regulatory and Study Conduct Best Practices

Regulatory challenges on Medicinal Product Studies - Challenges in Clinical Research

DEVELOPING CLINICAL TRIAL PROTOCOLS | CLINICAL TRIALS | REGULATORY AFFAIRS

Drug Development in a Post COVID World

DIA 2016 Editor’s Take – SynteractHCR

Foundations of Clinical Research

What is TMF Reference model||DIA||Trial master file||Clinical Research

Drug Development with Reimbursement in Mind

2009 DIA Euromeeting

What is the The European Medicines Agency?

South Korea: Navigating the Clinical Trial and Regulatory Environment

Theme 1 Access to Innovative Treatments - Susanna Del Signore

New Drug Development and Life Cycle Management

Global Regulatory Affairs 2018

The ever-expanding importance of diversity in clinical trials and drug development

Premarketing Clinical Trial Safety

09 Regulatory, Drug Safety

Orphan Drug Development | Episode 06 - USFDA vs EMA : Orphan Drug Designation | Regulatory Affairs

Panel: European Clinical Trials in a Global Context

Expert Tips for Pediatric Drug Development and Regulatory Success

Theme 1 Access to Innovative Treatments - Dorthe Poulsen

Cros Are The New Pharmas in Clinical Trials

Overview of Regulatory Affair #overview #regulatoryaffairs #clinicalresearch #jobsinclinicalresearch

DIA 2022: Strength in Numbers: Distilling RWE into Clinical Practice

What Factors Are Driving The Growth of Clinical Trials In the APAC Region?

COVID-19 Product Development & Clinical Trials: Considerations from European Regulatory Perspectives

Using real-world data for healthcare predictions

Disclaimer DMCA